Mayuree Rodrat, James N. Charlick, David N. Sheppard. "Chronic and acute modulator treatment restore wild-type-like activity and stability to the primary cystic fibrosis–causing
                    <i>CFTR</i>
                    variant." Proceedings of the National Academy of Sciences, 2026. doi:10.1073/pnas.2523950123